Corporate Partners
Diamond Partners
Abbott Molecular
Platinum Partners


Gold Partners


Silver Partners


Life Technologies

Important Information

and 20th Anniversary Celebration
November 12-15, 2014
Realizing the Dream of Precision Medicine
With special address by Dr. Francis Collins

Corporate Workshop Day
November 12, 2014

Special Address by Dr. Francis Collins
November 12, 2014

Molecular Pathology Outreach Course
November 12, 2014

Exhibit Dates
November 13-15, 2014

Gaylord National Resort & Convention Center
National Harbor, MD
(Just outside Washington, DC)

Early (Reduced) Registration
September 10, 2014
Advance Registration
October 20, 2014
Hotel Reservations
October 20, 2014

How to Help

Corporate Support Opportunities
Donate to AMP


Linked In FaceBook Twitter
Project management using Podio



Lung Biomarker Guideline Revision in the Works

CAP, IASLC, and AMP have teamed up to revise the evidence-based guideline, "Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors."

View the Press Release

More information about the Guideline


AMP Releases "A Molecular Diagnostic Perfect Storm" Paper

January 8, 2015: White Paper addresses the convergence of regulatory and reimbursement forces that threaten patient care. "AMP is addressing the consequences of this gathering perfect storm of regulatory and reimbursement challenges directed against molecular diagnostic testing with recommendations designed to preserve patient access to these essential medical services" said AMP President, Janina Longtine, MD. More information...

View the Paper

View the Press Release


AMP has Strong Presence at FDA Workshop on LDTs

January 8, 2015: FDA's Public Workshop - Framework for Regulatory Oversight of LDTs, includes presentations by ten AMP members. Message emphasizes optimization of patient care through molecular diagnostics.

View the Press Release.


AMP Comments on "A Modernized Framework for Innovative Diagnostic Tests"

January 5, 2015: AMP responded to specific questions posed by the U.S. Energy and Commerce Committee regarding LTPs and spelled out clear recommendations for ensuring patient care.

View the Letter.


AMP 2014 Annual Meeting Wraps-up with Record Level Attendance

December 11, 2014: More than 1,900 attendees plus nearly as many exhibitors gathered for the AMP 2014 Annual Meeting. Highlights included an address by Francis Collins, a conversation with the FDA, and AMP's first ever Advocacy Day. Thanks to everyone who participated for making the meeting a success!

View the Press Release.


AMP Partners with AMA and others on Letter to the FDA re: Regulation of LDTs

November 18, 2014: AMP joined the AMA and numerous other organizations in writing a letter to the FDA asking them to withdrawal the proposed draft guidance which seeks to regulate laboratory developed tests (LDTs). The letter urges the FDA to engage in the notice and comment rulemaking process as required under the Administrative Procedures Act (APA).

View the co-signed Letter.


AMP Announces Award Winners

November 14, 2014: Uta Francke, MD was awarded the AMP Award for Excellence in Molecular Diagnostics; Aaron Bossler, MD, PhD received the AMP Meritorious Service Award, and Elaine Lyon, PhD, was presented with the Jeffrey A. Kant Leadership Award.

View the Press Release


AMP Establishes Informatics Subdivision!

November 13, 2014: AMP President, Elaine Lyon, PhD, announced the formation of the Informatics Subdivision. The groundswell of interest by AMP members clearly identified the need for a subdivision of the Association dedicated to informatics. .

View the Press Release


AMPlifications - November 2014 Issue

In this pre-Annual Meeing issue, check out highlights of the meeting as well as a snapshot of AMP's initiatives in the realms of education, advocacy, innovation & improved patient care.

View the Newsletter